A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.

A study led by NYU Langone Health researchers sheds light on how the major cancer gene BRCA2 determines which cancer cells ...

The devil is in my eyes. I am haunted inside. I didn’t kill anyone,” Yarimi said after the fatal crash, according to ...

There is something special going on inside NYU Langone’s thoracic surgery service line.  Not only does the thoracic surgery team perform more surgeries than the national average, it reports no 30- and ...

Previous skepticism turns to optimism as the first clinical trials for transplantation with genetically edited pig kidneys ...

Dr. Doris Day, a board-certified dermatologist, has barely any wrinkles at 62. She has had cosmetic treatments, but said that ...

MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts. If you want to ...

New York Yankee Brett Gardner, has experts warning about carbon monoxide dangers amid speculations. The teen died while on ...

Joanne Liu says her alma mater’s health system pulled her scheduled talk, which included discussions about funding cuts to ...

Dr. Joanne Liu, an N.Y.U. graduate, said the cancellation of her presentation on humanitarian crises was a sign of the ...

NYU Langone's Federal Work Study Program offers STEM students hands-on research experience with faculty mentors. Gain skills ...

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry ...